{"name":"Xiaorong Dong","slug":"xiaorong-dong","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiYEFVX3lxTE9NS3FGLVhIYVJfRXMyd0V3b2hDbWY1OGxnOEFSTXdWd0ZIVm4wQjZ0aXpUbUE2Wmg5UWE4U0YwdzFObXVTZEU3aUlKZGozTlp3bnNJOFVwOFhmdDVGejJWaw?oc=5","date":"2024-06-02","type":"pipeline","source":"NEJM","summary":"Osimertinib after Chemoradiotherapy in Stage III EGFR -Mutated NSCLC - NEJM","headline":"Osimertinib after Chemoradiotherapy in Stage III EGFR -Mutated NSCLC","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE9iNVhkZWVoU0ZWLXJQSlhvbDZMQnl3X25rUkZTLUlJY1MtdWxZRlZjYlItMmpnbWpXS0xRQnA4Z0RBYWpHVGFuUWRqSEpUaFlkcDdlR0dyVDBacm1JRGNn?oc=5","date":"2024-02-13","type":"trial","source":"Nature","summary":"A pivotal bridging study of lurbinectedin as second-line therapy in Chinese patients with small cell lung cancer - Nature","headline":"A pivotal bridging study of lurbinectedin as second-line therapy in Chinese patients with small cell lung cancer","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}